Market Overview

Zosano Pharma Says It Has ENough Cash To Fund Ongoing Operations Through mid-2016

Related ZSAN
Stocks Hitting 52-Week Lows
Benzinga's Top Downgrades

"Including the proceeds of Zosano's January 2015 IPO and concurrent private placement, the company's cash and equivalents are expected to be sufficient to fund ongoing operations through mid-2016. This projection does not assume the receipt of any milestone payments from existing partners nor any funds from new financings or partnerships."

Posted-In: News


Related Articles (ZSAN)

View Comments and Join the Discussion!